Retinitis Pigmentosa (RP) is a hereditary retinopathy that affects about 2.5 million people
worldwide. It is characterized with progressive loss of rods and cones and causes severe …

Abstract The Argus® II Retinal Prosthesis System (Second Sight Medical Products) is the
first prosthetic vision device to obtain regulatory approval in both Europe and the USA. As …

Until recently, there was no approved treatment for a retinal degenerative disease.
Subretinal injection of a recombinant adeno-associated virus (AAV) delivering the normal …

Inherited retinal degenerations (IRDs) represent a diverse group of progressive, visually
debilitating diseases that can lead to blindness in which mutations in genes that are critical …

Retinal prosthesis systems have undergone significant advances in the past quarter century,
resulting in the development of several different novel surgical and engineering approaches …

Retinal degeneration, a leading cause of blindness worldwide, is primarily characterized by
the dysfunctional/degenerated photoreceptors that impair the ability of the retina to detect …

Purpose: We assessed the safety and efficacy of a technically advanced subretinal
electronic implant, RETINA IMPLANT Alpha AMS, in end stage retinal degeneration in an …

Retinal prostheses hold the promise of restoring vision in totally blind people. However, a
decade of clinical trials highlighted quantitative limitations hampering the possibility of …

Purpose The Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc,
Sylmar, CA) was developed to restore some vision to patients blind as a result of retinitis …

Late-stage retinal degenerative disease involving photoreceptor loss can be treated by
optogenetic therapy, cell transplantation and retinal prostheses. These approaches aim to …